Conference Overview
This two-day virtual conference, to be held May 10-11, 2024, is the leading meeting focused exclusively on cardiomyopathies in children. This conference series began in 2007 and occurs every 2-3 years with the last meeting attended by hundreds of global participants. The conference will convene top experts in the field of cardiology and genetics to determine research priorities and develop strategies for improving the management, treatment, and health outcomes of children with cardiomyopathy.
Purpose & Format
This meeting will bring together a multidisciplinary group of medical and healthcare professionals, including clinicians, genetic counselors, nurses, pharmacists, and researchers to discuss the most up-to-date evidence on the optimal management of pediatric cardiomyopathy and to shape the direction of future research on the disease. Through a combination of interactive presentations, case studies, panel discussions, and debates, the conference seeks to identify data gaps and needs, future research directions, new approaches and technologies that will lead to better outcomes, and improved preventive and interventional strategies.